Correlation of particle properties with cytotoxicity and cellular uptake of hydroxyapatite nanoparticles in human gastric cancer cells

Mater Sci Eng C Mater Biol Appl. 2016 Oct 1:67:453-460. doi: 10.1016/j.msec.2016.05.034. Epub 2016 May 7.

Abstract

Three types of hydroxyapatite nanoparticles (HAPNs) were synthesized employing a sonochemistry-assisted microwave method by changing microwave power (from 200 to 300W) or using calcination treatment: L200 (200W, lyophilization), L300 (300W, lyophilization) and C200 (200W, lyophilization & calcination). Their physiochemical properties were characterized and correlated with cytotoxicity to human gastric cancer cells (MGC80-3). The major differences among these HAPN preparations were their size and specific surface area, with the L200 showing a smaller size and higher specific surface area. Although all HAPNs inhibited cell proliferation and induced apoptosis of cancer cells, L200 exhibited the greatest toxicity. All types of HAPNs were internalized through energy-dependent pathways, but the L200 nanoparticles were more efficiently uptaken by MGC80-3 cells. Inhibitor studies with dynasore and methyl-β-cyclodextrin suggested that caveolae-mediated endocytosis and, to a much lesser extent, clathrin-mediated endocytosis, were involved in cellular uptake of the various preparations, whereas the inhibition of endocytosis was more obvious for L200. Using fluorescein isothiocyanate-labeled HAPNs and laser-scanning confocal microscopy, we found that all forms of nanoparticles were present in the cytoplasm, and some L200 HAPNs were even found within nuclei. Treatment with all HAPN preparations led to the increase in the intracellular calcium level with the highest level detected for L200.

Keywords: Cancer cell; Cytotoxicity; Hydroxyapatite nanoparticles; Intracellular calcium concentration; Particle properties; Uptake.

MeSH terms

  • Apoptosis / drug effects*
  • Cell Line, Tumor
  • Cell Nucleus / metabolism
  • Cell Nucleus / pathology
  • Cell Proliferation / drug effects*
  • Cytoplasm / metabolism
  • Cytoplasm / pathology
  • Cytotoxins* / chemistry
  • Cytotoxins* / pharmacokinetics
  • Cytotoxins* / pharmacology
  • Durapatite* / chemistry
  • Durapatite* / pharmacokinetics
  • Durapatite* / pharmacology
  • Humans
  • Nanoparticles / chemistry*
  • Stomach Neoplasms* / drug therapy
  • Stomach Neoplasms* / metabolism
  • Stomach Neoplasms* / pathology

Substances

  • Cytotoxins
  • Durapatite